Manel Pladevall (Manel Pladevall-Vila)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 16

Top Topics

Urinary Tract Infection

Extracorporeal Membrane Oxygenation

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Manel Pladevall, Anton Pottegård, Tania Schink, Johan Reutfors, Rosa Morros, Beatriz Poblador-Plou, Antje Timmer, Joan Forns, Maja Hellfritzsch, Tammo Reinders, David Hägg, Maria Giner-Soriano, Alexandra Prados-Torres, Miguel Cainzos-Achirica, Jesper Hallas, Lena Brandt, Jordi Cortés, Jaume Aguado, Gabriel Perlemuter, Bruno Falissard, Jordi Castellsagué, Emmanuelle Jacquot, Nicolas Deltour, Susana Perez-Gutthann
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. CNS drugs 33 (4) (2020)
Antje Timmer, Dominik de Sordi, Sanny Kappen, Klaus Peter Kohse, Cristina Rebordosa, Susanna Perez-Gutthann, Emmanuelle Jacquot, Nicolas Deltour, Manel Pladevall
Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany. Pharmacoepidemiology and drug safety 28 (10) (2019)